Clinical Trial Update: S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated thalidomide in combination with chemotherapy and peripheral stem cell transplantation for multiple myeloma; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2013-07-17